Dexmedetomidine activates mitophagy and protects against pyroptosis in oxygen-glucose deprivation/reperfusion-induced brain damage PINK1/Parkin pathway activation

Antonopoulos C, Russo HM, Sanadi E, Martin C, Li BN, Kaiser X, W. J., et al (2015) Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling. J Biol Chem 290(33):20167–20184. https://doi.org/10.1074/jbc.M115.652321

Article  CAS  PubMed  PubMed Central  Google Scholar 

Campbell BCV, De Silva DA, Macleod MR, Coutts SB, Schwamm LH, Davis SM et al (2019) Ischaemic stroke. Nat Rev Dis Primers 5(1):70. https://doi.org/10.1038/s41572-019-0118-8

Article  PubMed  Google Scholar 

Chen H, Kim GS, Okami N, Narasimhan P, Chan PH (2011) NADPH oxidase is involved in post-ischemic brain inflammation. Neurobiol Dis 42(3):341–348. https://doi.org/10.1016/j.nbd.2011.01.027

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen Y, Fan Z, Wu Q (2021) Dexmedetomidine improves oxygen-glucose deprivation/reoxygenation (OGD/R) -induced neurological injury through regulating SNHG11/miR-324-3p/VEGFA axis. Bioengineered 12(1):4794–4804. https://doi.org/10.1080/21655979.2021.1957071

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen C, Chen Y, Liu T, Song D, Ma D, Cheng O (2022a) Dexmedetomidine can enhance PINK1/Parkin-Mediated Mitophagy in MPTP-Induced PD mice Model by activating AMPK. Oxid Med Cell Longev 2022(7511393). https://doi.org/10.1155/2022/7511393

Chen S, Li A, Wu J, Huang Y, Zou T, Tailaiti T et al (2022b) Dexmedetomidine reduces myocardial ischemia-reperfusion injury in young mice through MIF/AMPK/GLUT4 axis. BMC Anesthesiol 22(1):289. https://doi.org/10.1186/s12871-022-01825-z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chen ZR, Hong Y, Wen SH, Zhan YQ, Huang WQ (2023) Dexmedetomidine Pretreatment Protects against Myocardial Ischemia/Reperfusion Injury by activating STAT3 signaling. Anesth Analg 137(2):426–439. https://doi.org/10.1213/ANE.0000000000006487

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cummins N, Gotz J (2018) Shedding light on mitophagy in neurons: what is the evidence for PINK1/Parkin mitophagy in vivo? Cell Mol Life Sci 75(7):1151–1162. https://doi.org/10.1007/s00018-017-2692-9

Article  CAS  PubMed  Google Scholar 

Deng X, Ye F, Zeng L, Luo W, Tu S, Wang X et al (2022) Dexmedetomidine mitigates myocardial Ischemia/Reperfusion-Induced mitochondrial apoptosis through Targeting lncRNA HCP5. Am J Chin Med 50(6):1529–1551. https://doi.org/10.1142/S0192415X22500641

Article  CAS  PubMed  Google Scholar 

Ge S, Zhang L, Cui X, Li Y (2022) Protective effects of brain-targeted dexmedetomidine nanomicelles on mitochondrial dysfunction in astrocytes of cerebral ischemia/reperfusion injury rats. Neuroscience 498:203–213. https://doi.org/10.1016/j.neuroscience.2022.07.005

Article  CAS  PubMed  Google Scholar 

Guo Q, Ma M, Yu H, Han Y, Zhang D (2023) Dexmedetomidine enables copper homeostasis in cerebral ischemia/reperfusion via ferredoxin 1. Ann Med 55(1):2209735. https://doi.org/10.1080/07853890.2023.2209735

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ham PB 3rd, Raju R (2017) Mitochondrial function in hypoxic ischemic injury and influence of aging. Prog Neurobiol 157:92–116. https://doi.org/10.1016/j.pneurobio.2016.06.006

Article  CAS  PubMed  Google Scholar 

Hou H, Zhang Y, Huang Y, Yi Q, Lv L, Zhang T et al (2012) Inhibitors of phosphatidylinositol 3’-kinases promote mitotic cell death in HeLa cells. PLoS ONE 7(4):e35665. https://doi.org/10.1371/journal.pone.0035665

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu Y, Zhou H, Zhang H, Sui Y, Zhang Z, Zou Y et al (2022) The neuroprotective effect of dexmedetomidine and its mechanism. Front Pharmacol 13:965661. https://doi.org/10.3389/fphar.2022.965661

Article  CAS  PubMed  PubMed Central  Google Scholar 

Iadecola C, Buckwalter MS, Anrather J (2020) Immune responses to stroke: mechanisms, modulation, and therapeutic potential. J Clin Invest 130(6):2777–2788. https://doi.org/10.1172/JCI135530

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johnson BN, Charan RA, LaVoie MJ (2012) Recognizing the cooperative and independent mitochondrial functions of Parkin and PINK1. Cell Cycle 11(15):2775–2776. https://doi.org/10.4161/cc.21261

Article  CAS  PubMed  PubMed Central  Google Scholar 

Keating GM (2015) Dexmedetomidine: a review of its use for Sedation in the Intensive Care setting. Drugs 75(10):1119–1130. https://doi.org/10.1007/s40265-015-0419-5

Article  CAS  PubMed  Google Scholar 

Lan R, Wu JT, Wu T, Ma YZ, Wang BQ, Zheng HZ et al (2018) Mitophagy is activated in brain damage induced by cerebral ischemia and reperfusion via the PINK1/Parkin/p62 signalling pathway. Brain Res Bull 142:63–77. https://doi.org/10.1016/j.brainresbull.2018.06.018

Article  CAS  PubMed  Google Scholar 

Latz E, Xiao TS, Stutz A (2013) Activation and regulation of the inflammasomes. Nat Rev Immunol 13(6):397–411. https://doi.org/10.1038/nri3452

Article  CAS  PubMed  Google Scholar 

Li J, Yang D, Li Z, Zhao M, Wang D, Sun Z et al (2023a) PINK1/Parkin-mediated mitophagy in neurodegenerative diseases. Ageing Res Rev 84:101817. https://doi.org/10.1016/j.arr.2022.101817

Article  CAS  PubMed  Google Scholar 

Li J, Wang K, Liu M, He J, Zhang H, Liu H (2023b) Dexmedetomidine alleviates cerebral ischemia-reperfusion injury via inhibiting autophagy through PI3K/Akt/mTOR pathway. J Mol Histol 54(3):173–181. https://doi.org/10.1007/s10735-023-10120-1

Article  CAS  PubMed  Google Scholar 

Liang S, Wang Y, Liu Y (2019) Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway. Eur Rev Med Pharmacol Sci 23(1):370–377. https://doi.org/10.26355/eurrev_201901_16785

Article  CAS  PubMed  Google Scholar 

Liaquat Z, Xu X, Zilundu PLM, Fu R, Zhou L (2021) The current role of Dexmedetomidine as Neuroprotective Agent: an updated review. Brain Sci 11(7). https://doi.org/10.3390/brainsci11070846

Lin Y, Wei Y, Wei Y, Yu H, Zhang W, Li C et al (2023) Dexmedetomidine alleviates oxidative stress and mitochondrial dysfunction in diabetic peripheral neuropathy via the microRNA-34a/SIRT2/S1PR1 axis. Int Immunopharmacol 117:109910. https://doi.org/10.1016/j.intimp.2023.109910

Article  CAS  PubMed  Google Scholar 

Liu K, Sun Y, Gu Z, Shi N, Zhang T, Sun X (2013) Mitophagy in ischaemia/reperfusion induced cerebral injury. Neurochem Res 38(7):1295–1300. https://doi.org/10.1007/s11064-013-1033-0

Article  CAS  PubMed  Google Scholar 

Lyu J, Zhou Y, Zhang M, Tang L, Bao X, Sun Z et al (2023) Neuroprotective effect of Dexmedetomidine on Cerebral Ischemia-Reperfusion Injury in rats. Altern Ther Health Med 29(6):164–169

PubMed  Google Scholar 

Mahmoud M, Mason KP (2015) Dexmedetomidine: review, update, and future considerations of paediatric perioperative and periprocedural applications and limitations. Br J Anaesth 115(2):171–182. https://doi.org/10.1093/bja/aev226

Article  CAS  PubMed  Google Scholar 

Mao Z, Tian L, Liu J, Wu Q, Wang N, Wang G et al (2022) Ligustilide ameliorates hippocampal neuronal injury after cerebral ischemia reperfusion through activating PINK1/Parkin-dependent mitophagy. Phytomedicine 101:154111. https://doi.org/10.1016/j.phymed.2022.154111

Article  CAS  PubMed  Google Scholar 

McLelland GL, Soubannier V, Chen CX, McBride HM, Fon EA (2014) Parkin and PINK1 function in a vesicular trafficking pathway regulating mitochondrial quality control. EMBO J 33(4):282–295. https://doi.org/10.1002/embj.201385902

Article 

Comments (0)

No login
gif